Stock RXRX RECURSION PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Recursion Pharmaceuticals, Inc.

Equities

RXRX

US75629V1044

Real-time Estimate Cboe BZX
Other stock markets
 01:11:46 2024-04-29 pm EDT 		5-day change 1st Jan Change
8.375 USD +3.14% Intraday chart for Recursion Pharmaceuticals, Inc. +9.74% -15.42%
Apr. 18 Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing MT
Apr. 16 Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing
MT
Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer
MT
Recursion Appoints Najat Khan as Chief R&D Officer and Chief Commercial Officer
CI
Recursion Pharmaceuticals Insider Sold Shares Worth $537,190, According to a Recent SEC Filing
MT
Recursion Pharmaceuticals, Inc. Appoints Kristen Rushton as Chief Business Operations Officer
CI
Recursion Pharmaceuticals Insider Sold Shares Worth $507,985, According to a Recent SEC Filing
MT
Recursion Pharmaceuticals Insider Sold Shares Worth $444,981, According to a Recent SEC Filing
MT
Recursion Pharmaceuticals, Inc. Announces Transition of Shafique Virani from the Chief Business Officer into Senior Strategic Advisor
CI
Recursion Pharmaceuticals Insider Sold Shares Worth $517,508, According to a Recent SEC Filing
MT
Recursion Pharmaceuticals Insider Sold Shares Worth $396,214, According to a Recent SEC Filing
MT
Recursion Pharmaceuticals Insider Sold Shares Worth $273,202, According to a Recent SEC Filing
MT
Recursion Pharmaceuticals Insider Sold Shares Worth $374,638, According to a Recent SEC Filing
MT
Recursion Pharmaceuticals Insider Sold Shares Worth $448,394, According to a Recent SEC Filing
MT
Recursion Pharmaceuticals Insider Sold Shares Worth $117,180, According to a Recent SEC Filing
MT
Recursion Pharmaceuticals Insider Sold Shares Worth $340,929, According to a Recent SEC Filing
MT
Recursion Pharmaceuticals Insider Sold Shares Worth $321,301, According to a Recent SEC Filing
MT
Recursion Pharmaceuticals Insider Sold Shares Worth $348,075, According to a Recent SEC Filing
MT
Recursion Pharmaceuticals Insider Sold Shares Worth $431,025, According to a Recent SEC Filing
MT
Recursion Pharmaceuticals Insider Sold Shares Worth $155,880, According to a Recent SEC Filing
MT
Insider Sell: Recursion Pharmaceuticals
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RXRX Stock
  4. News Recursion Pharmaceuticals, Inc.
  5. Insiders